Supplier News

Harm Reduction Therapeutics and Catalent Sign Commercial Supply Agreement

March 24, 2023

Harm Reduction Therapeutics and Catalent have signed a commercial supply agreement for naloxone nasal spray to reverse opioid overdoses.

Curia and Corning Collaborate to Advance Biopharmaceutical Continuous-Flow Development

March 24, 2023

Curia is collaborating with Corning to advance biopharmaceutical continuous-flow development and manufacturing programs.

Scorpius BioManufacturing Announces New Microbial Capacity and New Interim President

March 22, 2023

In addition to a new interim president, the company is opening new microbial capacity at its San Antonio facility and has plans to construct a commercial-scale facility in Manhattan, Kan.

TrakCel and Lonza Reach Integration Milestone to Combine Cell and Gene Therapy Manufacturing, Orchestration Solutions

March 22, 2023

The combined solutions are currently available on the market.

PurePep EasyClean Services Set to Accelerate Development and Manufacturing of Peptide-based Drugs

March 22, 2023

The services are based on the company’s PurePrep EasyClean (PEC) orthogonal peptide purification technology.

Sartorius and Teknova Team Up for Gene Therapy Process Development

March 21, 2023

Sartorius BIA Separations and Teknova will collaborate to combine their technologies in an effort to streamline the downstream purification process.

Samsung Biologics to Build Plant 5 as Part of Capacity Expansion to Bio Campus II

March 21, 2023

Samsung Biologics plans to invest more than ₩1.9 trillion (US$1.5 billion) in the new Incheon, South Korea, facility, which will hold a manufacturing capacity of 180,000 L.

Polyplus Introduces Novel LNP Formulation for Use in mRNA Therapeutics

March 17, 2023

Polyplus’ LipidBrick is designed to expand the scope of lipid nanoparticle formulation usage in mRNA therapeutics and vaccine development.

Stevanato Group and Recipharm to Collaborate on Pre-fillable Syringes for Soft Mist Inhaler

March 17, 2023

Stevanato Group will support development and production of pre-fillable syringes for use in Recipharm’s soft mist inhalers.

Catalent Licenses Bhami Research Laboratory Technology for Biologics Formulation Development

March 17, 2023

Under a technology licensing agreement with Bhami Research Laboratory, Catalent intends to develop formulations that will allow for the delivery of high-concentration biologics subcutaneously.